No basis for the claim of 39% gross margins. Even Rfmd only claimed an improvement of $20m over a year, kicking in towards the end of this year. That is an incremental 1.6% to existing 35.5% resulting in 37.1% gross margin some time late 2013 early 2014, far beyond the market's six month discounting.
The increased utilizations and improved product mix might get them 1% in gross margins to 36.5% this summer, and then to 38% by year end with the sourcing change.
The non-gaap eps figures posted make no sense at all.
The pps makes sense at $7 to mid-$8 but the market may inject a psychological component to drive the price to $9.
Getting nine women pregnant to have a child in one month is not how it works.